SLYND (drospirenone)
SELF ADMINISTRATION - Oral
Indications for Prior Authorization:
- Slynd® is a progestin indicated for use by females of reproductive potential to prevent pregnancy.
Prior Authorization Criteria:
- Patient has tried and failed a preferred Norethindrone (progesterone only) contraceptive (e.g., Camila®, Errin®, Heather, Incassia®, Jencycla™) as confirmed by prior authorization documentation and/or paid prescription claims history.
Dosing:
- One tablet is taken daily for 28 days (one white active tablet daily during the first 24 days and one green inert tablet daily during the 4 following days).
Approval:
Last review date: July 30, 2020